Emmaus Life Sciences, Inc. Common Stock
EMMA
EMMA was delisted on the 10th of September, 2019.
1 hedge funds and large institutions have $14K invested in Emmaus Life Sciences, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 9 closing their positions.
82% less capital invested
Capital invested by funds: $79K → $14K (-$65K)
89% less funds holding
Funds holding: 9 → 1 (-8)
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
Top Buyers
| 1 |
MWNA
Marshall Wace North America
New York
|
+$33K |
Top Sellers
| 1 |
CC
Cannell & Co
New York
|
-$26K |
| 2 |
FFA
First Foundation Advisors
Irvine,
California
|
-$21K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$16K |
| 4 |
Goldman Sachs
New York
|
-$15K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MWNA
1
Marshall Wace North America
New York
| $14K | +$33K | +6,008 | New |
|
|
CC
2
Cannell & Co
New York
| – | -$26K | -3,333 | Closed |
|
|
FFA
3
First Foundation Advisors
Irvine,
California
| – | -$21K | -2,667 | Closed |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| – | -$16K | -2,024 | Closed |
|
|
5
Goldman Sachs
New York
| – | -$15K | -1,969 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$1K | -191 | Closed |
|
EMMA Hedge Fund Activity: Q3 2019 in Review
1 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Emmaus Life Sciences, Inc. Common Stock (EMMA) for Q3 2019, worth a combined $14K — down 82% from $79K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of EMMA and 1 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Marshall Wace North America, opening a new position worth an estimated $33K. The largest seller was Cannell & Co, exiting entirely with an estimated $26K sold.
- 1 institutional investor held Emmaus Life Sciences, Inc. Common Stock (EMMA) as of Q3 2019, down from 9 in Q2 2019.
- Funds reported $14K of Emmaus Life Sciences, Inc. Common Stock stock for Q3 2019, down 82% quarter-over-quarter.
- 1 fund opened new Emmaus Life Sciences, Inc. Common Stock positions in Q3 2019 and 9 closed out, a net change of -8 holders.
- The largest Emmaus Life Sciences, Inc. Common Stock buyer in Q3 2019 was Marshall Wace North America, an estimated $33K added.
- The largest Emmaus Life Sciences, Inc. Common Stock seller in Q3 2019 was Cannell & Co, an estimated $26K sold.
Based on aggregated 13F filings for Q3 2019.